1h Free Analyst Time
The publisher has been monitoring the hemophilia therapeutics market and it is poised to grow by $ 4.47 bn during 2021-2025, progressing at a CAGR of 6.16% during the forecast period. The report on the hemophilia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by new drug approvals and the increasing number of initiatives to create awareness about hemophilia.
The hemophilia therapeutics market analysis includes the type segment and geographic landscape.
The hemophilia therapeutics market is segmented as below:
By Type
- Hemophilia A
- Hemophilia B
- Hemophilia C
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the regulatory incentives as one of the prime reasons driving the hemophilia therapeutics market growth during the next few years.
The report on hemophilia therapeutics market covers the following areas:
- Hemophilia therapeutics market sizing
- Hemophilia therapeutics market forecast
- Hemophilia therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hemophilia therapeutics market vendors that include Baxter International Inc., Bayer AG, Biogen Inc., CHIESI Farmaceutici SpA, CSL Ltd., F. Hoffmann-La Roche Ltd., Novo Nordisk AS, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd. Also, the hemophilia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Hemophilia A - Market size and forecast 2020-2025
- Hemophilia B - Market size and forecast 2020-2025
- Hemophilia C - Market size and forecast 2020-2025
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Baxter International Inc.
- Bayer AG
- Biogen Inc.
- CHIESI Farmaceutici SpA
- CSL Ltd.
- F. Hoffmann-La Roche Ltd.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Type - Market share 2020-2025 (%)
- Comparison by Type
- Hemophilia A - Market size and forecast 2020-2025 ($ million)
- Hemophilia A - Year-over-year growth 2020-2025 (%)
- Hemophilia B - Market size and forecast 2020-2025 ($ million)
- Hemophilia B - Year-over-year growth 2020-2025 (%)
- Hemophilia C - Market size and forecast 2020-2025 ($ million)
- Hemophilia C - Year-over-year growth 2020-2025 (%)
- Market opportunity by Type
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Key customers
- Baxter International Inc. - Segment focus
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- Biogen Inc. - Overview
- Biogen Inc. - Business segments
- Biogen Inc. - Key offerings
- Biogen Inc. - Key customers
- Biogen Inc. - Segment focus
- CHIESI Farmaceutici SpA - Overview
- CHIESI Farmaceutici SpA - Product and service
- CHIESI Farmaceutici SpA - Key offerings
- CHIESI Farmaceutici SpA - Key customers
- CHIESI Farmaceutici SpA - Segment focus
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key offerings
- CSL Ltd. - Key customers
- CSL Ltd. - Segment focus
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Business segments
- F. Hoffmann-La Roche Ltd. - Key offerings
- F. Hoffmann-La Roche Ltd. - Key customers
- F. Hoffmann-La Roche Ltd. - Segment focus
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Key customers
- Novo Nordisk AS - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key offerings
- Sanofi SA - Key customers
- Sanofi SA - Segment focus
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product and service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- Takeda Pharmaceutical Co. Ltd. - Key customers
- Takeda Pharmaceutical Co. Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global hemophilia therapeutics market: Baxter International Inc., Bayer AG, Biogen Inc., CHIESI Farmaceutici SpA, CSL Ltd., F. Hoffmann-La Roche Ltd., Novo Nordisk AS, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is regulatory incentives.`
According to the report, one of the major drivers for this market is the new drug approvals.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter International Inc.
- Bayer AG
- Biogen Inc.
- CHIESI Farmaceutici SpA
- CSL Ltd.
- F. Hoffmann-La Roche Ltd.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
